Baxter International Inc. company logo

# 1st Gen Model Baxter International Inc. Surgical & medical instruments

48.48% successful of 99 deals
$63.88 Last close price
at 17-nov-2017

BAX

Model's trade recommendations 3.31% Return for period

-14.65% Annual return

$34.80B Market Cap

β 0.68  

BAX

Model (following trade recommendations)

BAX

Underlying stock

S&P 500

Index
Return for period 3.31%
-0.37%
1.78%
52wk return -18.21%
35.97%
16.82%
52wk Range
43.63—65.68
2000.54—2399.63
Sortino ratio -1.63
Sharpe ratio -1.42
Norm. RMSE 0.20%
Downside risk 9.56%
Volatility 10.97%
  • 0.64 (1.00%) Div (Yield)
  • BUY Analysts consensus recommendation

Baxter engages in the worldwide development, manufacture and distribution of a diversified line of products, systems and services used primarily in the health-care field. The company's products are used by hospitals, clinical and medical research laboratories, blood and dialysis centers, rehabilitation centers, nursing homes, doctors' offices and by patients, at home, under physician supervision.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Baxter International Inc. (BAX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for BAX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 545M
P/E 26.40
Shares Outstanding 545M
% Held by Insiders 0.05%
% Held by Institutions 83.49%
EPS (last reported FY) $1.96
EPS (last reported Q) $0.64
EPS, estimated (last reported Q) $0.59
Total revenues $10 B
Net income $5 B